We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
-1.23%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$300M
AUM Growth
+$12.2M
Cap. Flow
+$19.5M
Cap. Flow %
6.5%
Top 10 Hldgs %
38.79%
Holding
113
New
9
Increased
9
Reduced
35
Closed
13

Top Buys

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$8.11M
2
AMGN icon
Amgen
AMGN
+$6.68M
3
CI icon
Cigna
CI
+$6.42M
4
META icon
Meta Platforms (Facebook)
META
+$5.43M
5
FLEX icon
Flex
FLEX
+$5.28M

Top Sells

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$1.81M
2
BIB icon
ProShares Ultra NASDAQ Biotechnology
BIB
+$1.76M
3
BX icon
Blackstone
BX
+$1.39M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.26M
5
IMBI
iMedia Brands, Inc. Class A Common Stock
IMBI
+$1.11M

Sector Composition

Rank Sector Weight
1 Healthcare 27.15%
2 Communication Services 17.59%
3 Technology 15.86%
4 Industrials 9.86%
5 Miscellaneous 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
51
Johnson & Johnson
JNJ
$646B
$856K 0.29%
6,682
– –
TRGP icon
52
Targa Resources
TRGP
$61.7B
$841K 0.28%
19,122
– –
BMRN icon
53
BioMarin Pharmaceuticals
BMRN
$12.5B
$811K 0.27%
+10,000
New +$858K
BALL icon
54
Ball Corp
BALL
$16.9B
$805K 0.27%
20,260
– –
FSTX
55
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$805K 0.27%
13,084
– –
KO icon
56
Coca-Cola
KO
$386B
$782K 0.26%
18,000
– –
TROW icon
57
T. Rowe Price
TROW
$23.7B
$640K 0.21%
5,930
– –
PH icon
58
Parker-Hannifin
PH
$125B
$637K 0.21%
3,727
– –
LLL
59
DELISTED
L3 Technologies, Inc.
LLL
$624K 0.21%
3,000
– –
GILD icon
60
Gilead Sciences
GILD
$181B
$619K 0.21%
8,207
+1,082
+15% +$86K
VSTM icon
61
Verastem
VSTM
$654M
$562K 0.19%
+15,704
New +$608K
BIB icon
62
ProShares Ultra NASDAQ Biotechnology
BIB
$98.9M
$551K 0.18%
10,000
-29,397
-75% -$1.76M
FWONA icon
63
Liberty Media Series A
FWONA
$23.4B
$548K 0.18%
19,540
-129
-0.7% -$4.02K
AEP icon
64
American Electric Power
AEP
$66.6B
$536K 0.18%
7,810
-1,005
-11% -$67.7K
CVS icon
65
CVS Health
CVS
$119B
$526K 0.18%
8,450
– –
LBRDA
66
DELISTED
Liberty Broadband Class A
LBRDA
$510K 0.17%
6,018
-62
-1% -$5.55K
MDSO
67
DELISTED
Medidata Solutions, Inc.
MDSO
$465K 0.15%
7,400
– –
LSXMK
68
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$437K 0.15%
14,049
– –
LRCX icon
69
Lam Research
LRCX
$378B
$422K 0.14%
+20,750
New +$411K
ETP
70
DELISTED
Energy Transfer Partners, L.P.
ETP
$414K 0.14%
25,540
+1,015
+4% +$18.9K
DISH
71
DELISTED
DISH Network Corp.
DISH
$400K 0.13%
10,550
– –
NXH
72
Neighborhood Intelligence Inc
NXH
$375M
$391K 0.13%
+14,356
New +$673K
FWONK icon
73
Liberty Media Series C
FWONK
$25.5B
$368K 0.12%
12,330
-258
-2% -$8.54K
MSFT icon
74
Microsoft
MSFT
$3.81T
$365K 0.12%
4,003
– –
TXN icon
75
Texas Instruments
TXN
$236B
$361K 0.12%
3,475
– –
1 2
3
4

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Private Capital Advisors held 113 positions worth $300M, up 4.2% from $288M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Private Capital Advisors deployed $19.5M of net new capital in Q1 2018, opening 9 new positions and adding to 9 existing holdings. Its largest new stake was Amgen: 36,375 shares worth $6.2M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was ProShares Ultra NASDAQ Biotechnology, an estimated $1.76M trimmed.

  • Private Capital Advisors's largest Q1 2018 buy was Amgen: 36,375 shares worth $6.2M.
  • Private Capital Advisors added most to iShares Biotechnology ETF in Q1 2018, an estimated $8.11M increase.
  • Private Capital Advisors's biggest Q1 2018 reduction was ProShares Ultra NASDAQ Biotechnology, cutting an estimated $1.76M.
  • Private Capital Advisors fully exited Halliburton in Q1 2018, selling an estimated $1.81M.
  • Private Capital Advisors's ten largest holdings make up 39% of its $300M portfolio in Q1 2018.
  • Private Capital Advisors opened 9 new positions and closed 13 in Q1 2018.
  • Private Capital Advisors's portfolio value rose 4.2% quarter-over-quarter to $300M.

Based on Private Capital Advisors's 13F filing for Q1 2018, filed 18 Apr 2018.